focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,110.00
Bid: 12,086.00
Ask: 12,088.00
Change: -56.00 (-0.46%)
Spread: 2.00 (0.017%)
Open: 12,186.00
High: 12,198.00
Low: 12,068.00
Prev. Close: 12,166.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON BRIEFING: Lloyds Banking to Embark on wealth management drive

Thu, 29th Jul 2021 08:23

(Alliance News) - Lloyds Bankings on Thursday followed peer Barclays in announcing a big improvement to second-quarter results, while also restoring its payout and announcing an acquisition to accelerate its push into wealth management.

Lloyds said it swung to a GBP3.91 billion pretax profit in the first half of 2021, from a GBP602 million loss a year earlier.

The lender's net income rose 2.0% to GBP7.56 billion from GBP7.41 billion. Net interest margin was 2.5%, which it guided for the rest of 2021 as well.

Lloyds was boosted by an impairment credit of GBP656 million in the first half, following a GBP3.82 billion hit a year earlier.

It resumed interim dividends by declaring a 0.67 pence per share payout, having not made on in the first half of 2020. The dividend is 18% higher than its 0.57p payout for the second half of 2020.

"During the first six months of 2021, the group has delivered a solid financial performance with continued business momentum, bolstered by an improved macroeconomic outlook for the UK," interim CEO William Chalmers said.

In addition, Lloyds announced plans to acquire investment and retirement platform Embark Group for GBP390 million.

"Embark enhances the group's capabilities to address the attractive mass market and self-directed Wealth segment, completing its Wealth proposition. Embark will also enable the group to re-platform its pensions and retirement proposition, delivering a market-leading platform for intermediaries and significantly strengthening its offering in Retirement, an important growth market," Lloyds said.

Embark, which will become part of Scottish Widows, brings GBP35 billion in assets under administration for 410,000 consumer clients. It has seven UK offices - in London, Bolton, Dundee, Edinburgh, Leeds, Leicester and Swindon - and includes the brands Advance, Horizon, Stocktrade, Vested and The Adviser Centre.

The purchase will have a 30 basis points impact on Lloyds' group CET1 ratio, which sat at 16.7% at the end of the first half.

"Our acquisition of Embark will not only help us serve all of a customer's financial needs in one place, but also sit alongside our existing partnerships which meet the more complex financial planning and investment requirements of mass-affluent and high net-worth customers through Schroders Personal Wealth and Cazenove Capital," explained Antonio Lorenzo, chief executive of Scottish Widows & group director of Insurance & Wealth.

Lloyds shares up 1.4% early Thursday in London, outperforming the wider FTSE 100 index.

Here is what you need to know at the London market open:

----------

MARKETS

----------

FTSE 100: up 0.4% at 7,043.64

----------

Hang Seng: up 3.0% at 26,230.04

Nikkei 225: closed up 0.7% at 27,782.42

DJIA: closed down 127.59 points, 0.4%, at 34,930.93

S&P 500: closed down 0.82 of a point at 4,400.64

Nasdaq Composite: closed up 0.7% at 14,762.58

----------

EUR: up at USD1.1852 (USD1.1807)

GBP: up at USD1.3929 (USD1.3881)

USD: down at JPY109.83 (JPY110.09)

Gold: up at USD1,819.05 per ounce (USD1,800.47)

Oil (Brent): up at USD75.16 a barrel (USD74.62)

(changes since previous London equities close)

----------

ECONOMICS AND GENERAL

----------

Thursday's Key Economic Events still to come

0955 CEST Germany labour market statistics

1100 CEST EU business & consumer surveys

1400 CEST Germany provisional CPI

0930 BST UK monetary & financial statistics

0830 EDT US advance estimate GDP

0830 EDT US unemployment insurance weekly claims report

1030 EDT US EIA weekly natural gas storage report

----------

A shallow 8.2 magnitude earthquake struck off the Alaskan peninsula late Wednesday, the US Geological Survey said, prompting a tsunami warning. The earthquake hit 56 miles southeast of the town of Perryville, the USGS said, with a tsunami warning in effect for south Alaska and the Alaskan peninsula. The US government issued a tsunami warning for Alaska's southeast.

----------

BROKER RATING CHANGES

----------

BARCLAYS CUTS UDG HEALTHCARE TO 'EQUAL WEIGHT' (OVERWEIGHT) - TARGET 1,080 (975) PENCE

----------

HSBC CUTS WIZZ AIR TO 'REDUCE' (HOLD) - PRICE TARGET 4,100 (4,500) PENCE

----------

HSBC CUTS PENNON TO 'REDUCE' (HOLD)

----------

COMPANIES - FTSE 100

----------

Oil major Royal Dutch Shell said it is "stepping up" shareholder returns. Shell said it has rebased its second quarter dividend to 24 US cents, up 38% quarter-on-quarter. For the second quarter of last year, it had declared a 16 cents payout. In addition, Shell is targeting USD2 billion in buybacks which it aims to complete by the end of 2021.Chief Executive Ben van Beurden said: "We are stepping up our shareholder distributions today, increasing dividends and starting share buybacks, while we continue to invest for the future of energy." He added: "Total shareholder distributions for 2021 are expected to be around the middle of the 20-30% range of [cash flow from operations] from the previous four quarters. Our progressive dividend policy to grow dividends per share by 4% annually, subject to board approval, remains unchanged." Shell said it saw "another quarter of operational and financial delivery". It swung to a USD3.43 billion profit attributable to shareholders, from a USD18.13 billion loss a year earlier. Shell posted pretax profit of USD4.13 billion, swinging from a USD23.91 billion loss a year prior. Second quarter total revenue, so including joint-ventures, surged 90% to USD61.76 billion from USD32.49 billion.

----------

Miner Anglo American also set out plans to return USD2 billion to investors. It will buyback USD1 billion, and it declared a special payout of USD0.80 per share, equal to USD1 billion. Finance Director Stephen Pearce explained: "As a result of our prudent approach to capital allocation, including our commitment to our established base dividend policy of returning 40% of underlying earnings to our shareholders, our balance sheet is in a strong position." The buyback will kick off immediately and end "no later" than February 14. In addition, Anglo lifted its regular half-year payout to USD1.71 per share, from USD0.28 a year earlier. Anglo noted that including the buyback and special dividend, its interim payout is USD3.31 per share. In the six months to June 30, Anglo American's revenue more than doubled to USD21.78 billion from USD10.19 billion. Pretax profit surged to USD10.70 billion from USD1.56 billion. CEO Mark Cutifani said: "The first six months of 2021 have seen strong demand and prices for many of our products as economies begin to recoup lost ground, spurred by stimulus measures across the major economies."

----------

AstraZeneca said its Covid vaccine generated USD1.2 billion in sales in the first half of the year. The group added in its interim results statement that it shipped about 319 million doses worldwide during the period, which included USD572 million of sales in Europe and USD455 million in emerging markets. Overall first half revenue was USD15.54 billion, up 23% from a year before. Pretax profit rose 25% to USD2.37 billion. Astra declared an unchanged first interim dividend of USD0.90 per shares. It expects revenue to increase by a low-twenties percentage in the full year.

----------

Brewer and distiller Diageo reported an 81% rise in annual pretax profit to GBP3.71 billion from GBP2.04 billion the year before. Net sales in the financial year that ended June 30 were GBP12.73 billion, up 8% from GBP11.75 billion and up 16% on an organic basis. Volumes rose by 10%, or 11% organically, while Diageo's operating margin improved dramatically to 29.3% from 18.2%. Diageo declared a 72.55 pence total dividend, up 4% from 69.88p in financial 2020.

----------

COMPANIES - GLOBAL

----------

Airbus said it bounced back strongly into profit in the first half of the year as aircraft deliveries rose, leading the company to revise its performance forecasts upwards. Airbus posted a net profit of EUR2.2 billion for the first six months of 2021, compared to a loss of EUR1.9 billion last year as the airline industry was walloped by the Covid-19 pandemic. Airbus said it delivered 297 aircraft between January and June against 196 last year. As clients pay most of the cost of the aircraft upon delivery, revenues jumped 30% to EUR24.6 billion. The European plane manufacturer now expects to deliver 600 planes this year, instead of the previously estimated 566, the number delivered in 2020.

----------

Swiss food and drink company Nestle raised its full-year organic sales growth guidance after reporting higher year-on-year sales and profit in the first half. In the six months ended June 30, Nestle's underlying trade operating profit grew to CHF7.25 billion, around USD7.98 billion, up 1.3% from CHF7.16 billion in the same period a year prior, with an underlying profit margin of 17.4%. Sales also grew modestly in the first half, rising 1.5% to CHF41.76 billion from CHF41.15 billion the year before. Organic growth reached 8.1%, the company said, with real internal growth of 6.8% and pricing up 1.3%. The nutrition firm updated its full-year outlook for 2021, predicting full-year organic sales growth between 5% and 6%.

----------

Anheuser-Busch InBev reported a strong performance in the second quarter of the year, with annual earnings possibly seen growing in the double-digit range. AB InBev is a Leuven, Belgium-based drink and brewing company which owns brands such as Corona and Budweiser. Underlying profit attributable to equity holders surged 45% to USD2.61 billion in the second quarter to end-June from USD1.80 billion a year prior. Revenue rose 21% to USD25.83 billion from USD21.30 billion.

----------

Robinhood has said its mission is to "democratize finance for all", and that stretches to its plan for the company's debut on public markets Thursday. The online investment platform, which is expected to begin trading under the ticker symbol "HOOD" on the Nasdaq, has set aside up to 35% of the shares under its initial public offering for sale to its users. On Wednesday, the company said it raised USD1.9 billion in an initial public offering priced at USD38 per share, at the low end of the range in its prospectus and giving a USD32 billion valuation. Robinhood, whose commission-free stock trading model has been copied by some rivals, had USD81 billion in assets under its custody at the end of March, up from USD14.2 billion at the end of 2019.

----------

Thursday's Shareholder Meetings

Amiad Water Systems Ltd - AGM

Aminex PLC - AGM

B&M European Value Retail SA - AGM

CMC Markets PLC - AGM

De La Rue PLC - AGM

discoverIE Group PLC - AGM

Dr Martens PLC - AGM

GB Group PLC - AGM

Intermediate Capital Group PLC - AGM

Johnson Matthey PLC - AGM

Ovoca Bio PLC - AGM

Palace Capital PLC - AGM

Playtech PLC - GM re Finalto sale

Powerhouse Energy Group PLC - AGM

Tate & Lyle PLC - AGM

Volex PLC - AGM

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
16 May 2024 10:27

AstraZeneca trials yield positive results for immunocompromised patients

(Alliance News) - AstraZeneca PLC on Thursday said results from recent trials revealed a significant reduction in cases of Covid-19.

Read more
12 May 2024 13:25

Pfizer and AstraZeneca announce new investments of nearly $1 billion in France

PARIS, May 12 (Reuters) - Leading healthcare companies Pfizer and AstraZeneca announced on Sunday new investments in France worth a total of nearly $1 billion, ahead of the start of this year's annual 'Choose France' business summit.

Read more
8 May 2024 19:10

Sector movers: Aerospace and Defence, Pharma pace gains

(Sharecast News) - London's main stock market gauges continued to push higher in the middle of the week, even as investors waited on the Bank of England's policy announcement on the following day.

Read more
8 May 2024 17:46

FTSE 100 hits record high, pound slips ahead of BoE verdict

FTSE 100 up 0.5%, FTSE 250 adds 0.4%

*

Read more
8 May 2024 16:36

London close: Stocks rise further ahead of BoE decision

(Sharecast News) - London's stock markets closed with gains on Wednesday, bolstered by a dip in the value of the pound against both the dollar and the euro.

Read more
8 May 2024 09:44

AstraZeneca says withdraws Covid vaccine "for commercial reasons"

(Alliance News) - Drugmaker AstraZeneca PLC said Wednesday that it has withdrawn its Covid vaccine Vaxzevria, one of the first produced in the pandemic, citing "commercial reasons" and a surplus of updated jabs.

Read more
8 May 2024 09:39

LONDON BROKER RATINGS: UBS raises Centrica to 'buy' from 'neutral

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
7 May 2024 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
7 May 2024 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.